Relapse of myelin oligodendrocyte glycoprotein antibody-associated demyelinating disease in an elderly patient after long-term remission

Yumiko Mayuzumi¹, Yu Kitazawa^{2

3}, Tonguk Kunimatsu^{1

4}

Affiliations

¹ Department of Neurology, Tokyo Rosai Hospital, Ota, Tokyo, 143-0013, Japan.
² Department of Neurology, Tokyo Rosai Hospital, Ota, Tokyo, 143-0013, Japan. yu_kitazawa@wayne.edu.
³ Department of Pediatrics, Children's Hospital of Michigan, Wayne State University, 3901 Beaubien St., Detroit, MI, 48201, USA. yu_kitazawa@wayne.edu.
⁴ Department of Neurology, Dokkyo Medical University, Mibu, Tochigi, 321-0293, Japan.

Yumiko Mayuzumi et al. Acta Neurol Belg. 2023 Aug.

. 2023 Aug;123(4):1531-1532.

doi: 10.1007/s13760-022-01983-4. Epub 2022 Jun 22.

Yumiko Mayuzumi¹, Yu Kitazawa^{2

3}, Tonguk Kunimatsu^{1

4}

¹ Department of Neurology, Tokyo Rosai Hospital, Ota, Tokyo, 143-0013, Japan.
² Department of Neurology, Tokyo Rosai Hospital, Ota, Tokyo, 143-0013, Japan. yu_kitazawa@wayne.edu.
³ Department of Pediatrics, Children's Hospital of Michigan, Wayne State University, 3901 Beaubien St., Detroit, MI, 48201, USA. yu_kitazawa@wayne.edu.
⁴ Department of Neurology, Dokkyo Medical University, Mibu, Tochigi, 321-0293, Japan.

No abstract available

References

1. Dauby S, Dive D, Lutteri L et al (2022) Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort. Acta Neurol Belg 122:135–144. https://doi.org/10.1007/s13760-021-01712-3 - DOI - PubMed
1. Epstein SE, Levin S, Onomichi K et al (2021) Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: the difficulty of predicting relapses. Multiple Sclerosis Relat Disord 56:103229. https://doi.org/10.1016/j.msard.2021.103229 - DOI
1. Marignier R, Hacohen Y, Cobo-Calvo A et al (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20:762–772. https://doi.org/10.1016/S1474-4422(21)00218-0 - DOI - PubMed
1. Akaishi T, Misu T, Takahashi T et al (2021) Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders. J Neuroimmunol 351:1–4. https://doi.org/10.1016/j.jneuroim.2020.577467 - DOI
1. Sechi E, Buciuc M, Pittock SJ et al (2021) Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing. JAMA Neurol 55905:1–6. https://doi.org/10.1001/jamaneurol.2021.0912 - DOI